1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)

Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)

NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of the Opioid Crisis as renewed in Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis.
The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent Early Stage Investigator of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD). Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.

Funding Opportunity Details

RFA-TR-22-013
None

Dana K. Andersen, M.D.

Key Dates

1/28/2022

15 days prior to the application due date